Medication info

Jungwon Heart Arrest Solution No. 1

Prescription medication
Ingredient · strength
Sodium Chloride›6.43g / 1000mLPotassium Chloride›1.193g / 1000mLCalcium Chloride Hydrate›0.176g / 1000mLMagnesium Chloride Hydrate›3.253g / 1000mL
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Colorless and transparent liquid in a polypropylene multi-layer film plastic container
Packaging
500mL/box
Approval status
Active

MFDS item code 198700175 · Notified 1987.09.28

Summary

Main use
Induction of cardiac arrest and myocardial protection during open-heart surgery
Who uses it
Adults
Adult dosage
1. This solution must be used after adding sodium bicarbonate (10mL of 8.4% sodium bicarbonate per 1000mL of this solution) and within 24 hours. 2. Cool the solution to 4℃ and, immediately after aortic cross-clamping, perfuse it into the aortic root using the cardiopulmonary bypass circuit's motor pump for coronary perfusion. In general, the physician determines the initial perfusion volume, subsequent perfusion volume and number of repeat perfusions, extracorporeal circulation time, aortic cross-clamp time, and infusion pressure according to the patient's condition and the progress of surgery. At the same time as perfusion, inject normal saline or Ringer's solution cooled to 4℃ into the thoracic cavity to induce local cooling around the heart. The local cooling solution should be replaced continuously or periodically to maintain adequate cooling. Remove the perfused solution by suction through an incision in the right atrium or right ventricle. A thermistor probe may be used to monitor myocardial temperature.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Induction of cardiac arrest and myocardial protection during open-heart surgery

View approved original text

This perfusion solution is used to prevent cardiac arrest that may occur during open-heart surgery and to protect the myocardial. It helps to maintain heart function during surgery and minimizes damage. Therefore, it plays an important role in supporting the safe and effective progress of open-heart surgery and aiding in patient recovery.

Dosage and Administration

Adult dosage

1. This solution must be used after adding sodium bicarbonate (10mL of 8.4% sodium bicarbonate per 1000mL of this solution) and within 24 hours. 2. Cool the solution to 4℃ and, immediately after aortic cross-clamping, perfuse it into the aortic root using the cardiopulmonary bypass circuit's motor pump for coronary perfusion. In general, the physician determines the initial perfusion volume, subsequent perfusion volume and number of repeat perfusions, extracorporeal circulation time, aortic cross-clamp time, and infusion pressure according to the patient's condition and the progress of surgery. At the same time as perfusion, inject normal saline or Ringer's solution cooled to 4℃ into the thoracic cavity to induce local cooling around the heart. The local cooling solution should be replaced continuously or periodically to maintain adequate cooling. Remove the perfused solution by suction through an incision in the right atrium or right ventricle. A thermistor probe may be used to monitor myocardial temperature.

Precautions

This medication must be combined with sodium bicarbonate before use. Caution is required when perfusing this medication in large volumes, as high levels of magnesium and potassium in the blood can occur if it is not removed by direct suction from the right atrium or right ventricle. When administered to patients undergoing open-heart surgery, there is a potential for cardiac-related issues such as myocardial infarction, ECG abnormalities, arrhythmias, and ventricular fibrillation. Additionally, overdose of this medication may cause tissue edema, so dosage adjustment should be monitored. This medication must be administered by a physician experienced in open-heart surgery, and it is important to continuously monitor the heart temperature to maintain a state of hypothermia during surgery. When used, this medication should be injected only into the cardiovascular system, and intravenous injection is strictly prohibited. Furthermore, it should only be used as a perfusion solution in cases of aortic occlusion, and it should not be used if the solution is cloudy or if the container is damaged. Any remaining solution should not be reused and should be discarded.

Side effects

  • Myocardial infarction
  • electrocardiogram abnormalities
  • arrhythmia
  • ventricular fibrillation
  • tissue edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. This will help maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Colorless and transparent liquid in a polypropylene multi-layer film plastic container

Package unit

500mL/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.